Search results for "Lemi"

showing 10 items of 513 documents

Decreased plasma soluble RAGE in patients with hypercholesterolemia: Effects of statins

2007

The receptor for advanced glycation endproducts (RAGE) is overexpressed at sites of vascular pathology. A soluble RAGE isoform (sRAGE) neutralizes the ligand-mediated damage by acting as a decoy. We hypothesized that in hypercholesterolemia up-regulation of the ligand-RAGE axis may bridge impairment of nitric oxide biosynthesis with oxidative stress. We measured in 60 hypercholesterolemic patients and 20 controls plasma total sRAGE levels, urinary 8-iso-prostaglandin (PG) F(2alpha) excretion, and plasma levels of asymmetric dimethylarginine (ADMA). The effects of two structurally different statins (pravastatin and atorvastatin) on these parameters were analyzed in 20 hypercholesterolemic su…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaStatinmedicine.drug_classAtorvastatinHypercholesterolemiaReceptor for Advanced Glycation End ProductsFree radicalsArginineDinoprostNitric Oxidemedicine.disease_causeBiochemistrychemistry.chemical_compoundDouble-Blind MethodPhysiology (medical)Internal medicineHyperlipidemiaAtorvastatinmedicineHumansPyrrolesReceptors ImmunologicEndothelial dysfunctionPravastatinChemistryVascular diseaseAnticholesteremic AgentsStatinnutritional and metabolic diseasesMiddle AgedAtherosclerosismedicine.diseaseADMACross-Sectional StudiesHyperlipidemiaEndocrinologyHeptanoic AcidsOxidative streFemalelipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorsNitric Oxide SynthaseAsymmetric dimethylarginineOxidative stressPravastatinsRAGEmedicine.drugFree Radical Biology and Medicine
researchProduct

Effects of clinical and laboratory variables at admission and of in-hospital treatment with cardiovascular drugs on short term prognosis of ischemic …

2011

Abstract Introduction No information exists, to our knowledge, about the possible role of cardiovascular drug administration in the acute phase of ischemic stroke and possible effects on stroke outcome. The aim of our study was to evaluate the relationship between in-hospital treatment with cardiovascular drugs in patients with acute ischemic stroke and some outcome indicators. Methods and Results 1096 subjects enrolled in the GIFA study, who had a main discharge diagnosis of ischemic stroke represent the final sample. Drugs considered for the analysis were the following: ACE-inhibitors (ACEI), angiotensin II receptor blockers (ARBs), statins, calcium-channel-blockers (CCBs), antiplatelet (…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismHypercholesterolemiaMedicine (miscellaneous)Angiotensin II Receptor BlockersCharlson indexAngiotensin-Converting Enzyme InhibitorsComorbidityBrain IschemiaInternal medicineActivities of Daily LivingmedicineHumansIn patientcardiovascular diseasesStrokeGeriatric AssessmentAgedRetrospective StudiesNutrition and Dieteticsbusiness.industryCardiovascular AgentsHeparinmedicine.diseaseCalcium Channel BlockersPrognosisStrokeHospital treatmentItalyIschemic strokeHypertensionPhysical therapyFunctional statusFemaleCardiology and Cardiovascular MedicinebusinessCognition DisordersPlatelet Aggregation Inhibitorsmedicine.drugNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Effect of aqueous extract of Ajuga iva supplementation on plasma lipid profile and tissue antioxidant status in rats fed a high-cholesterol diet

2006

Abstract The present study was designed to explore the possible antioxidant and hypolipidemic effects of the aqueous extract of Ajuga iva (0.5% in the diet) in rats fed a high-cholesterol (1%) diet (HCD). The results indicated that the HCD-Ai versus HCD treatment led to many changes in biochemical parameters. They showed a decrease of plasma total cholesterol (TC) and VLDL-cholesterol but an increase of HDL2-cholesterol. The triacylglycerol contents were reduced in plasma and in VLDL. The lipid peroxidation determined by TBARS was decreased by 75% in plasma. TBARS in liver, heart and kidneys were highly reduced excepted in the adipose tissue. Ajuga iva treatment enhanced superoxide dismutas…

Malemedicine.medical_specialtyVery low-density lipoproteinAntioxidantLipoproteinsmedicine.medical_treatmentHypercholesterolemiaAdipose tissueAjugaThiobarbituric Acid Reactive SubstancesAntioxidantsAjugaCholesterol DietaryLipid peroxidationEatingchemistry.chemical_compoundInternal medicineDrug DiscoverymedicineTBARSAnimalsRats WistarPharmacologybiologyPlant ExtractsCholesterolBody WeightOrgan Sizebiology.organism_classificationLipidsDietEnzymesRatsEndocrinologychemistryDietary SupplementsIntestinal cholesterol absorptionlipids (amino acids peptides and proteins)Journal of Ethnopharmacology
researchProduct

Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and no…

2020

Patients with familial hypercholesterolemia (FH) are prone to develop acute myocardial infarction (AMI) at a younger age.The aim of the present study was to assess 5-year outcomes after AMI according to the presence of FH in a large multicenter cohort of patients.The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction consists of nationwide surveys recruiting patients over a 1- to 2-month period every 5 years. Patients recruited in 2005 and 2010 were followed up to 5 years.Of 5147 patients discharged alive and in whom FH status could be assessed, 2.8% had probable/definite FH, using an adapted Dutch Lipid Clinic score. They were 12 years younger, on average, tha…

Malemedicine.medical_specialty[SDV]Life Sciences [q-bio]Endocrinology Diabetes and MetabolismFamilial hypercholesterolemia030204 cardiovascular system & hematologyCohort StudiesHyperlipoproteinemia Type II03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineSurveys and QuestionnairesInternal MedicinemedicineHumansIn patient030212 general & internal medicineMyocardial infarctionRegistriesNon-ST Elevated Myocardial InfarctionStrokeComputingMilieux_MISCELLANEOUSAgedNutrition and Dieteticsbusiness.industryST elevationHazard ratioMiddle Agedmedicine.diseasePrognosisConfidence interval3. Good healthCohortST Elevation Myocardial Infarction[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFemaleFranceHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessJournal of clinical lipidology
researchProduct

New-Onset Diabetes and Statins: Throw the Bath Water Out, But, Please, Keep the Baby!

2015

Malemedicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismHypercholesterolemiamedicine.diseaseEndocrinologyEndocrinologyNew onset diabetesInternal medicineDiabetes MellitusmedicineHumansFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsMetabolic syndromebusinessMetabolism
researchProduct

Portulaca oleracea reduces triglyceridemia, cholesterolemia, and improves lecithin: cholesterol acyltransferase activity in rats fed enriched-cholest…

2014

Abstract Purpose The effects of Portulaca oleracea ( Po ) lyophilized aqueous extract were determined on the serum high-density lipoproteins (HDL 2 and HDL 3 ) amounts and composition, as well as on lecithin: cholesterol acyltansferase (LCAT) activity. Methods Male Wistar rats ( n  = 12) were fed on 1% cholesterol-enriched diet for 10 days. After this phase, hypercholesterolemic rats (HC) were divided into two groups fed the same diet supplemented or not with Portulaca oleracea ( Po -HC) (0.5%) for four weeks. Results Serum total cholesterol (TC) and triacylglycerols (TG), and liver TG values were respectively 1.6-, 1.8-, and 1.6-fold lower in Po -HC than in HC group. Cholesterol concentrat…

Malemedicine.medical_specialtyfood.ingredientHypercholesterolemiaPharmaceutical SciencePortulacaPortulacaLecithinCholesterol DietaryPhosphatidylcholine-Sterol O-Acyltransferasechemistry.chemical_compoundfoodInternal medicineDrug DiscoverymedicineAnimalsRats WistarTriglyceridesHypolipidemic AgentsPharmacologychemistry.chemical_classificationHypertriglyceridemiaChromatographybiologyCholesterolPlant ExtractsReverse cholesterol transportbiology.organism_classificationPlant LeavesEnzymeEndocrinologyCholesterolComplementary and alternative medicinechemistryLiverLecithin—cholesterol acyltransferasebiology.proteinMolecular Medicinelipids (amino acids peptides and proteins)Composition (visual arts)Acyl groupPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

Real-world study: Escalating targeted lipid-lowering treatment with PCSK9-inhibitors and lipoprotein apheresis.

2018

INTRODUCTION Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition with monoclonal antibodies has complemented the armamentarium of lipid-lowering therapy (LLT) before the final step of commencing chronic lipoprotein apheresis (LA). Data are scarce on patients who, after escalation of LLT with PCSK9 antibodies, have commenced chronic LA or PCSK9 antibody treatment during ongoing long-term LA. PATIENTS AND METHODS In this study, a cohort of 110 patients with established atherosclerotic cardiovascular disease (ASCVD) due to hypercholesterolemia or concomitant lipoprotein(a)-hyperlipoproteinemia, who received PCSK9 antibodies for the first time during routine care, were consecutivel…

Malemedicine.medical_specialtymedicine.drug_classLipoproteinsHypercholesterolemia030204 cardiovascular system & hematologyMonoclonal antibodyGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansEnzyme InhibitorsAdverse effectbiologybusiness.industryPCSK9PCSK9 InhibitorsAntibodies MonoclonalHematologyGeneral MedicineLipoprotein(a)Cholesterol LDLMiddle AgedAtherosclerosisCombined Modality TherapyLipidsDiscontinuationConcomitantCohortbiology.proteinBlood Component RemovalFemaleAntibodyProprotein Convertase 9business030215 immunologyLipoprotein(a)Journal of clinical apheresis
researchProduct

Potes meleiros e colmenas em cerâmica: una tradicâo milenar

2006

Neste estudo apresenta-se uma breve resenha sobre a importância do mel na antiguidade e destaca-se a existência de contentores destinados ao seu armazenamento. Tendo em conta a maior antiguidade destes contentores recolhidos na Península (datáveis, pelo menos, a partir de c. de 600 a.C.), a sua persitência ao longo dos tempos, e a existência de paralelos etnográficos ainda hoje documentados, admitimos tratar-se de uma tradicâo com origem da Península.Destaca-se, ainda, a importância dos mellaria na economia do mundo antigo e realça-se a identificacâo de colmeias em cerâmica na regiao de Valência e de uma inédita recolhida em Bracara Augusta, uma cidade romana localizada no extremo ocidente …

Mel; Potes Meleiros; Colemias em ceramica. Tradiçao milenarPotes MeleirosColemias em ceramica. Tradiçao milenarlcsh:Clcsh:Archaeologylcsh:CC1-960lcsh:Auxiliary sciences of historyArqueologíaMelSagvntum
researchProduct

Two cases of adynamia episodica hereditaria: In vitro investigation of muscle cell membrane and contraction parameters

1983

Membrane potentials, current-voltage relationships, and contractile parameters were studied in intact muscle cell bundles obtained from two patients with adynamia episodica hereditaria. In a normal extracellular medium, the cell membranes had resting potentials of about -80 mV and their current-voltage relationships were not significantly different from control curves. In contrast to normal muscles the afflicted cells were paralyzed in a medium having 6-10 mmol/liter potassium. The mechanisms of paralysis in the two specimens were different from each other. Many fibers from one patient were spontaneously active even in normal solution. In high potassium solution spontaneous activity was inc…

Membrane potentialbiologyPhysiologyNav1.4Potassiumchemistry.chemical_elementDepolarizationAnatomymedicine.diseaseCellular and Molecular Neurosciencechemistry.chemical_compoundchemistryPhysiology (medical)TetrodotoxinBiophysicsExtracellularbiology.proteinmedicineMyocyteNeurology (clinical)Hyperkalemic periodic paralysisMuscle & Nerve
researchProduct

Phenomenological ontology of breathing : the phenomenologico-ontological interpretation of the barbaric conviction of we breathe air and a new philos…

2018

The general topic of my philosophical dissertation is phenomenological ontology of breathing. I do not investigate the phenomenon of breathing as a natural scientific problem, but as a philosophical question. Within our tradition, breathing has been normally understood as a mechanistic-materialistic physiological life-sustaining process of gas exchange and cellular respiration which does not really seem to have any essential connection to human being’s spiritual, mental or philosophical capacities. On the contrary to this natural scientific view, I argue that breathing can be understood as a philosophical question that has phenomenological, experiential, ontological, spiritual, bodily, ment…

Merleau-Ponty MauricebreathingphilosophylyriikkafenomenologiahiljaisuuskuunteleminenIrigaray LuceHeidegger MartinhavainnotBachelard Gastonelementalsilencefilosofiahengitysphenomenologyontologyontologialisteningpoetry
researchProduct